HKD 2.0
(-3.38%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 91.58 Million HKD | 67.85% |
2022 | 54.56 Million HKD | 13.97% |
2021 | 47.87 Million HKD | -0.3% |
2020 | 48.01 Million HKD | -24.71% |
2019 | 63.77 Million HKD | 112.27% |
2018 | 30.04 Million HKD | -4.19% |
2017 | 31.35 Million HKD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2023 FY | 91.58 Million HKD | 67.85% |
2023 Q2 | 55.29 Million HKD | 0.0% |
2023 Q4 | 91.58 Million HKD | 0.0% |
2022 Q4 | 54.56 Million HKD | 0.0% |
2022 FY | 54.56 Million HKD | 13.97% |
2022 Q2 | 53.27 Million HKD | 0.0% |
2021 Q2 | 40.35 Million HKD | 0.0% |
2021 FY | 47.87 Million HKD | -0.3% |
2021 Q4 | 47.87 Million HKD | 0.0% |
2020 Q2 | - HKD | -100.0% |
2020 Q4 | 48.01 Million HKD | 0.0% |
2020 Q1 | 62.95 Million HKD | 0.0% |
2020 FY | 48.01 Million HKD | -24.71% |
2019 FY | 63.77 Million HKD | 112.27% |
2018 FY | 30.04 Million HKD | -4.19% |
2017 FY | 31.35 Million HKD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Pak Fah Yeow International Limited | 12.19 Million HKD | -650.881% |
Grand Pharmaceutical Group Limited | 1.38 Billion HKD | 93.405% |
Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -1160.633% |
Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | 70.274% |
Qianhai Health Holdings Limited | 431.78 Million HKD | 78.789% |
Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | 69.278% |
Essex Bio-Technology Limited | 62.82 Million HKD | -45.785% |
Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | 6.799% |
PuraPharm Corporation Limited | 175.59 Million HKD | 47.844% |
SSY Group Limited | 1.08 Billion HKD | 91.569% |
Jacobson Pharma Corporation Limited | 317.85 Million HKD | 71.187% |
China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 99.739% |